AGLYC project logo


The AGLYC project is about developing a new IVD test based on the quantification of specific protein modifications as a novel and disruptive approach to detect cardiac ischemia.


The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 826930 (Phase I) and No. 849047 (Phase II).

100  %
Production of AGLYC Reagents
30  %
Clinical Validation of AGLYC
30  %
Business Relevant Activities IP Protection
25  %
Regulatory Quality Management
45  %
Communication and Dissemination
50  %
Project Management
Glycardial Diagnostics

A GlyCardial Diagnostics’ Project

Latest News

Be the first to read

Prof. Juan Carlos Kaski as Chief Medical Officer of GlyCardial Diagnostics

© Copyright 2019. All rights reserved